SCHEMBL4746949

SCHEMBL4746949

Cc1cc(C(=O)O)nc(C)c1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALOX15 P16050 2/20 0.45
TSHR P16473 2/20 0.45
HIF1A Q16665 1/20 0.45
CYP3A4 P08684 2/20 0.44
ACHE P22303 1/20 0.44
KDM4E B2RXH2 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
IGFBP3 P17936 1/20 0.43
GPR35 Q9HC97 2/20 0.41
DAO P14920 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 3/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 2/20 0.39
RAB9A P51151 1/20 0.39
PDE10A Q9Y233 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2804478 0.82 ALOX15 (0.43) ALDH1A1MAPK1SMN1; SMN2ALOX15TSHR
SCHEMBL29415461 0.82 ALOX15 (0.43) ALDH1A1MAPK1SMN1; SMN2ALOX15TSHR
SCHEMBL11375028 0.82 IGFBP3 (0.49) ALDH1A1MAPK1SMN1; SMN2ALOX15TSHR
SCHEMBL31125623 0.81 ALDH1A1 (0.68) ALDH1A1MAPK1SMN1; SMN2CYP3A4ACHE
SCHEMBL5391695 0.81 ALDH1A1 (0.52) ALDH1A1MAPK1SMN1; SMN2ALOX15CYP3A4
SCHEMBL7788152 0.81 ALDH1A1 (0.68) ALDH1A1MAPK1SMN1; SMN2CYP3A4ACHE
SCHEMBL12641092 0.81 ALOX15 (0.46) ALDH1A1MAPK1SMN1; SMN2ALOX15TSHR
SCHEMBL22445800 0.79 ALDH1A1 (0.50) ALDH1A1MAPK1SMN1; SMN2ALOX15CYP3A4
SCHEMBL4073122 0.78 ALDH1A1 (0.39) ALDH1A1MAPK1SMN1; SMN2CYP3A4ACHE
SCHEMBL24665086 0.78 RXFP1 (0.44) ALDH1A1MAPK1SMN1; SMN2ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008109343-A1 METHODS OF TREATING BIPOLAR DISORDER AND MEMORY AND/OR COGNITIVE IMPAIRMENT ASSOCIATED THEREWITH WITH (+)-ISOPROPYL 2-METHOXYETHYL 4-(2-CHLORO-3-CYANO-PHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-PYRIDINE-3,5-DICARBOXYLATE MEMORY PHARMACEUTICALS CORPORATION (US) 2008-09-12 WO claimed
EP-0245918-B1 1,4-DIHYDROPYRIDINE DERIVATIVES GLAXO S.p.A. (IT) 1993-05-05 EP disclosed